DIVISLAB.NS or EFX: which has stronger momentum now?
As of 2026-09-01: DIVISLAB.NS LONG (218 bars, uPnL +40.9%, total return +25.3%) vs EFX LONG (28 bars, uPnL +5.7%, total return -45.1%). Momentum is the fourth gate — quality and valuation ceilings come first.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| DIVISLAB.NS (Divi's Laboratories) | EFX (Equifax) | |
| Market / sector | in · Pharma | us · Industrials |
| Price | ₹9,121 | $190.36 |
| Quality score | —/100 | 100/100 |
| Engine signal | LONG · 218 bars · uPnL +40.9% | LONG · 28 bars · uPnL +5.7% |
| Total return | +25.3% | -45.1% |
Cite this page
Balance Labs Research Desk (2026-09-01). "DIVISLAB.NS or EFX: which has stronger momentum now?." balancelabs.app · https://balancelabs.app/stocks/compare/divislab.ns-vs-efx/q/divislab.ns-or-efx-stronger-momentum · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← DIVISLAB.NS vs EFX · snapshot 2026-09-01 · not investment advice